Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China
· Delayed Price · Currency is CNY 15.58
+0.11 (0.71%)
Apr 3, 2025, 2:45 PM CST
Tasly Pharmaceutical Group Company Description
Tasly Pharmaceutical Group Co., Ltd engages in the pharmaceutical business in China and internationally.
The company provides prescription drugs covering various therapeutic areas, including cardiovascular and cerebrovascular, hepato-biliary-pancreatic, respiratory system, diabetes, tumor immunity, gastrointestinal disease, gynecological, rheumatism, soothe the nerves, pruritus, and andrological areas, as well as over-the-counter drugs.
Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is headquartered in Tianjin, China.
Tasly Pharmaceutical Group Co., Ltd
| Country | China |
| Founded | 1994 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 10,958 |
| CEO | Jin Yong Cai |
Contact Details
Address: 2 Pujihe East Road Tianjin, 300410 China | |
| Phone | 86 22 2673 6999 |
| Website | taslypharma.com |
Stock Details
| Ticker Symbol | 600535 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000001C81 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jin Yong Cai | GM and Director |
| Jie Wei | Chief Financial Officer and Head of Accounting |
| Yu Jie | Secretary and Vice President |
| Shunnan Zhang | Deputy GM and Supervisor |